Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05322876

Feasibility of Reducing Cardiovascular Disease Risk Factors in Hispanics Through a Family-Based Community Intervention

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Poudre Valley Health System · Academic / Other
Sex
All
Age
13 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the feasibility of a 6-month family-based community intervention to mitigate cardiovascular disease risk factors in Hispanic families in northern Colorado as measured through biometric screenings, body composition, physical activity, and health knowledge.

Detailed description

The current project aims to leverage the UCHealth Healthy Hearts Family Program to provide a free, non-insurance-based 1-year cardiovascular disease (CVD) prevention and wellness program to Hispanic Colorado families. This program includes an interactive educational class series, baseline and quarterly biometric screenings, and optional consultations with an Exercise Physiologist and a Dietitian. This program takes a novel approach to preventative care by incorporating the family unit with the intention of having the child be the agent of change. The long-term goals of this project are to significantly improve CVD risk factors among participating families and to disseminate study findings to inform developing and current outreach programs to offer effective CVD prevention programs for Hispanic citizens. This work may ultimately lead to more Hispanics being served through new or existing programs, therefore expanding important preventative community health interventions into this underserved population.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHealthy Hearts Family ProgramParticipants will participate in a baseline health and knowledge screening, followed by a 6-week once-weekly class series, and 3- and 6-month follow-up health and knowledge screenings.

Timeline

Start date
2022-03-22
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2022-04-12
Last updated
2024-04-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05322876. Inclusion in this directory is not an endorsement.